McKesson Corporation Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by McKesson Corporation on September 10, 2021. The report discloses a specific corporate governance event regarding the appointment of a senior executive officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on personnel changes and does not contain financial statement data.
Material Changes
The primary material change disclosed is the appointment of Kevin W. Emerson as Senior Vice President, Controller, and Chief Accounting Officer on an interim basis. This appointment was made to fill the vacancy while the Company completes its search for a permanent replacement.
Management Commentary and Risks
Mr. Emerson, age 49, joined McKesson in 2005 and has held various senior finance and accounting roles, including Controller of U.S. Pharmaceutical and Vice President, Corporate Initiatives. In his new interim role, he leads a team focused on global consolidations, reporting, external (SEC) reporting, technical accounting, corporate general ledger, and financial applications. He holds a Bachelor's degree in Accounting and Business Administration and is a CPA. The filing does not disclose specific risks, contingencies, or unusual items beyond the leadership transition.
Investor Verification Checklist
- Verify the timeline for the search process for a permanent Chief Accounting Officer.
- Review subsequent filings to confirm the appointment of a permanent replacement for the Controller role.
- Confirm that no other undisclosed executive departures occurred concurrently with this appointment.